Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Novalead Pharma Private Limited
- Target Recruit Count
- 176
- Registration Number
- NCT03998436
- Locations
- 🇮🇳
Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India
🇮🇳M.S. Ramaiah Medical College and Hospital, Bangalore, Karnataka, India
🇮🇳Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Novalead Pharma Private Limited
- Target Recruit Count
- 44
- Registration Number
- NCT01113515
- Locations
- 🇮🇳
M V Hospital for Diabetes Pvt. Ltd., Chennai, Tamil Nadu, India
🇲🇾Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
🇮🇳S.L. Raheja Hospital, Mumbai, Maharashtra, India
© Copyright 2025. All Rights Reserved by MedPath